You are currently viewing a new version of our website. To view the old version click .

Infectious Disease Epidemiology and Pharmaceutical Development

This special issue belongs to the section “Pharmacology“.

Special Issue Information

Dear Colleagues,

As we are all aware, the past few years have presented us with a number of new challenges related to the emergence and re-emergence of viral, bacterial or parasitic infections. These infectious diseases are responsible for difficult-to-control pandemics or epidemics, and conflicts at the global level have also led to, or may lead to, the reemergence of conditions that were considered eradicated in recent decades. This has increased vigilance in the medical field and has made it imperative that we invest in intensive epidemiological surveillance, clinical and etiological diagnosis, and effective pharmaceutical research. This will ultimately lead to effective etiological and pathogenetic therapy, as well as prevention through vaccination.

The dynamic of infectious diseases is a challenge for everyone!

To combat these challenges, we need to work together and pool our knowledge and expertise. With this in mind, we would like to invite you to contribute to this Special Issue of Pharmaceuticals. We are looking for impactful manuscripts in the areas of epidemiology and pharmaceutical development related to infectious diseases. We want to hear about your personal and institutional efforts in recent years, as well as your knowledge and expertise in the field.

We welcome both reviews and original articles in the field of epidemiology of infectious diseases and pharmaceutical development. The topics we are interested include but are not limited to viral infections, re-emerging bacterial infections, healthcare-associated infections, tropical diseases, antibiotic resistance, and new therapeutic methods. By sharing our knowledge and experience, we can work towards better understanding and management of these diseases.

We look forward to receiving your submissions.

Prof. Dr. Victoria Bîrluţiu
Dr. Simin Aysel Florescu
Dr. Oana Săndulescu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • viral infections
  • bacterial infections
  • healthcare-associated infections
  • tropical diseases
  • epidemiology of infectious diseases
  • antibiotic resistance
  • vaccination
  • epidemiology of bone and joint infections

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247